UK markets closed

BerGenBio ASA (BGBIOO.XC)

Cboe UK - Cboe UK Real-time price. Currency in NOK
Add to watchlist
0.26830.0000 (0.00%)
At close: 02:00PM BST
Currency in NOK

Valuation measures4

Market cap (intra-day) 463.18M
Enterprise value 345.83M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)554.95
Price/book (mrq)6.51
Enterprise value/revenue 1.08k
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.43
52-week change 326,730.00%
S&P500 52-week change 322.55%
52-week high 326.8300
52-week low 30.1000
50-day moving average 315.1429
200-day moving average 33.9606

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 539.09M
Implied shares outstanding 62.91B
Float 817.5M
% held by insiders 135.39%
% held by institutions 110.45%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 330 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-23,810.18%

Management effectiveness

Return on assets (ttm)-90.00%
Return on equity (ttm)-276.78%

Income statement

Revenue (ttm)521k
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -159.04M
Net income avi to common (ttm)-154.52M
Diluted EPS (ttm)-55.4100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)117.35M
Total cash per share (mrq)4.36
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)3.21
Book value per share (mrq)3.47

Cash flow statement

Operating cash flow (ttm)-192.32M
Levered free cash flow (ttm)-125.59M